Interview with Joan Alvarez, Country Manager, Lundbeck Philippines
You have been involved with Lundbeck since the beginning of its operations in the Philippines. How has the company evolved since you joined seven years ago to be where it…
Address: 6/F Electra House Building, 115-117 Esteban Street, Legaspi Village, Makati City 1200 ,Philippines
Tel: +632 817-3021
Web: http://www.lundbeck.com/global
Lundbeck is a global pharmaceutical company conducting research into, developing, manufacturing, marketing, selling and distributing pharmaceuticals for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, epilepsy and insomnia.
Lundbeck employs 5,900 people worldwide, 2,100 of whom are based in Denmark. Employees are present in 56 countries, and products are registered in more than 100 countries. The production facilities are located in Italy and Denmark and the research centres in Denmark and the USA.
Lundbeck Philippines started its operations as a representative office in 2003.
Lundbeck markets a number of different pharmaceuticals for the treatment of disorders of the central nervous system (CNS). The most recently launched compounds include: Cipralex/Lexapro (depression), Ebixa (Alzheimer’s disease), Azilect (Parkinson’s disease), Xenazine (chorea associated with Huntington’s disease), Serdolect (schizophrenia), Sabril (epilepsy) and Circadin (sleep disorders).
You have been involved with Lundbeck since the beginning of its operations in the Philippines. How has the company evolved since you joined seven years ago to be where it…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Al Z. Castro, General Manager of IMS Health Philippines, speaks about the ongoing challenges of bringing about awareness and acceptance of generics medicine to the local population, how this will…
Ibrahim Monchito, Deputy Executive Director of the Department of Science and Technology ICT Office stresses the need to bring higher value to the HIM industry as a means to protect…
Pedro Miranda Jr., General Manager of Pacific Healthcare Philippines, talks about the decision to join Pacific Healthcare in the Philippines, how the company’s diversification strategy has evolved over the past…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Thelma Tobias–Go, President of the Philippine Chamber of the Pharmaceutical Industry and Scheele Laboartories, and Ed Ocampo, COO and Vice President of Scheele Laboratories, discuss the implications of the changing…
Jason Carroll, General Manager of Janssen Philippines, discusses what it will take to put Janssen Philippines on the map as one of the largest, most reputable pharmaceutical companies in the…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Julita Geronimo, President & CEO of Globo Asiatico, Philippines, talks about her motivation to start Globo Asiatico, how the company must drive up sales to continue to grow as a…
Raul Manlapig, Principal Managing Director of Arup, Philippines, talks about the current rapid growth of the country’s economy, how the company’s sustained presence in many countries around the world provides…
See our Cookie Privacy Policy Here
